Epilepsy Research and Data
Research and Data
The Epilepsy Foundation believe that more research is vitally important to the movement for compassionate access. Unfortunately, it has been difficult for scientists and researchers to organize clinical trials due to marijuana being a Schedule I drug. That is why we have been working to reschedule marijuana and allow more scientific studies on the impact it can have as a treatment.
Study: CBD From Marijuana Plus Chemotherapy Tripled Cancer Survival Rates In Mice
Study: CBD From Marijuana Plus Chemotherapy Tripled Cancer Survival Rates In Mice David DiSalvo |Read More
NORML exec: The case for whole-plant cannabis
NORML exec: The case for whole-plant cannabis Paul Armentano | July 22, 2018 Emergency rulesRead More